Sapovirus vaccine

Immunogenic compositions with sapovirus antigens, produced using baculovirus/insect cell techniques, address the challenges of sapovirus infections by inducing an effective immune response and preventing transmission.

JP7832236B2Active Publication Date: 2026-03-17VST LLC DBA MEDGENE LABS
View PDF -1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-06-28
Publication Date
2026-03-17
Patent Text Reader

Abstract

The present invention describes immunogenic compositions comprising immunogenic polypeptides of Sapovirus, including immunogenic compositions comprising antigens other than Sapovirus antigens, including antigens that can be used in immunizing against pathogens that cause diarrheal disease. Methods of eliciting an immune response using the disclosed immunogenic compositions and methods of treating Sapovirus infection are also described.
Need to check novelty before this filing date? Find Prior Art